OverviewChartNewsTraderScreen

Protalix BioTherapeutics Inc/  US74365A1016  /

IEX
30/05/2024  21:59:55 Chg. +0.02 Volume Bid- Ask- High Low
1.15USD +1.33% 7,662
Turnover: 8,776.30		 -Bid Size: - -Ask Size: - 1.16 1.13
GlobeNewswire 30/11/2023 Levicept Appoints Eliot Forster as CEO
GlobeNewswire 02/08/2021 Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cG...
GlobeNewswire 08/06/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTher...
GlobeNewswire 02/02/2021 Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its B...
GlobeNewswire 02/10/2020 Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Launch of Expanded Access Program ...
GlobeNewswire 20/02/2020 Galectin Therapeutics Appoints Seasoned Biopharmaceutical Executive Pol F. Boudes, M.D. as Chief Med...
GlobeNewswire 30/08/2019 Protalix BioTherapeutics Receives Listing Deficiency Letter from NYSE American
GlobeNewswire 22/08/2019 Protalix BioTherapeutics Focuses on Evaluating and Pursuing Alternatives to Maximize Shareholder Val...
GlobeNewswire 13/08/2019 Shlomo Yanai Resigns as Chairman of the Board of Protalix BioTherapeutics
GlobeNewswire 08/08/2019 Protalix BioTherapeutics Reports Second Quarter 2019 Results and Provides Corporate Update
GlobeNewswire 29/07/2019 Protalix BioTherapeutics to Hold Second Quarter 2019 Financial Results and Corporate Update Conferen...
GlobeNewswire 29/07/2019 Protalix BioTherapeutics Appoints Eyal Rubin as its New Senior Vice President and Chief Financial Of...
GlobeNewswire 17/07/2019 Global Fabry Disease Treatment Market Review 2017-2019 & Forecast to 2025 - Focus on Enzyme Replacem...
GlobeNewswire 17/06/2019 Protalix BioTherapeutics Completes Enrollment in the Phase III BRIGHT Clinical Trial of pegunigalsid...
GlobeNewswire 06/06/2019 Protalix BioTherapeutics and Chiesi Farmaceutici S.p.A to Apply for Accelerated Approval of peguniga...
GlobeNewswire 21/05/2019 Protalix BioTherapeutics Appoints Dror Bashan as its New President and Chief Executive Officer and D...
GlobeNewswire 06/05/2019 Protalix BioTherapeutics Reports 2019 First Quarter Results and Provides Corporate Update
GlobeNewswire 29/04/2019 Protalix BioTherapeutics to Hold First Quarter 2019 Financial Results and Corporate Update Conferenc...
GlobeNewswire 12/04/2019 Research Report Identifies TTM Technologies, Zumiez, Global Net Lease, Catabasis Pharmaceuticals, Bi...
GlobeNewswire 18/03/2019 Protalix BioTherapeutics Reports 2018 Full Year Results and Provides Corporate Update
GlobeNewswire 13/03/2019 Protalix BioTherapeutics to Postpone the 2018 Financial Results and Corporate Update Conference Call
GlobeNewswire 06/03/2019 Protalix BioTherapeutics to Hold Full-Year 2018 Financial Results and Corporate Update Conference Ca...
GlobeNewswire 14/02/2019 Global Fabry Disease Market Insights, Epidemiology and Market Forecast 2019-2028
GlobeNewswire 05/02/2019 Protalix BioTherapeutics Presents Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for...
GlobeNewswire 29/01/2019 New Research: Key Drivers of Growth for Voya Financial, Conduent, Milacron, Altair Engineering, Gene...